Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2016 2
2018 2
2019 7
2020 8
2021 2
2022 7
2023 4
2024 14
2025 15
2026 14

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

67 results

Results by year

Filters applied: . Clear all
Page 1
Vutrisiran in Patients with Transthyretin Amyloidosis with Cardiomyopathy.
Fontana M, Berk JL, Gillmore JD, Witteles RM, Grogan M, Drachman B, Damy T, Garcia-Pavia P, Taubel J, Solomon SD, Sheikh FH, Tahara N, González-Costello J, Tsujita K, Morbach C, Pozsonyi Z, Petrie MC, Delgado D, Van der Meer P, Jabbour A, Bondue A, Kim D, Azevedo O, Hvitfeldt Poulsen S, Yilmaz A, Jankowska EA, Algalarrondo V, Slugg A, Garg PP, Boyle KL, Yureneva E, Silliman N, Yang L, Chen J, Eraly SA, Vest J, Maurer MS; HELIOS-B Trial Investigators. Fontana M, et al. N Engl J Med. 2025 Jan 2;392(1):33-44. doi: 10.1056/NEJMoa2409134. Epub 2024 Aug 30. N Engl J Med. 2025. PMID: 39213194 Clinical Trial.
[Drug-induced cardiomyopathies].
Michel L, Rassaf T. Michel L, et al. Dtsch Med Wochenschr. 2022 Nov;147(23):1513-1522. doi: 10.1055/a-1810-9275. Epub 2022 Nov 16. Dtsch Med Wochenschr. 2022. PMID: 36384152 German.
Targeting early stages of cardiotoxicity from anti-PD1 immune checkpoint inhibitor therapy.
Michel L, Helfrich I, Hendgen-Cotta UB, Mincu RI, Korste S, Mrotzek SM, Spomer A, Odersky A, Rischpler C, Herrmann K, Umutlu L, Coman C, Ahrends R, Sickmann A, Löffek S, Livingstone E, Ugurel S, Zimmer L, Gunzer M, Schadendorf D, Totzeck M, Rassaf T. Michel L, et al. Eur Heart J. 2022 Jan 31;43(4):316-329. doi: 10.1093/eurheartj/ehab430. Eur Heart J. 2022. PMID: 34389849 Free article.
Stroke and myocardial infarction induce neutrophil extracellular trap release disrupting lymphoid organ structure and immunoglobulin secretion.
Tuz AA, Ghosh S, Karsch L, Ttoouli D, Sata SP, Ulusoy Ö, Kraus A, Hoerenbaum N, Wolf JN, Lohmann S, Zwirnlein F, Kaygusuz V, Lakovic V, Tummes HL, Beer A, Gallert M, Thiebes S, Qefalia A, Cibir Z, Antler M, Korste S, Haj Yehia E, Michel L, Rassaf T, Kaltwasser B, Abdelrahman H, Mohamud Yusuf A, Wang C, Yin D, Haeusler L, Lueong S, Richter M, Engel DR, Stenzel M, Soehnlein O, Frank B, Solo-Nomenjanahary M, Ho-Tin-Noé B, Siveke JT, Totzeck M, Hoffmann D, Grüneboom A, Hagemann N, Hasenberg A, Desilles JP, Mazighi M, Sickmann A, Chen J, Hermann DM, Gunzer M, Singh V. Tuz AA, et al. Among authors: michel l. Nat Cardiovasc Res. 2024 May;3(5):525-540. doi: 10.1038/s44161-024-00462-8. Epub 2024 Apr 23. Nat Cardiovasc Res. 2024. PMID: 39195931 Free PMC article.
Cardio-oncology: need for novel structures.
Michel L, Rassaf T. Michel L, et al. Eur J Med Res. 2019 Jan 3;24(1):1. doi: 10.1186/s40001-018-0359-0. Eur J Med Res. 2019. PMID: 30606260 Free PMC article.
[Heart and cancer: cardio-oncology].
Michel L, Rassaf T. Michel L, et al. Herz. 2024 Mar;49(2):111-117. doi: 10.1007/s00059-024-05232-7. Epub 2024 Jan 30. Herz. 2024. PMID: 38289420 Review. German.
Cardiotoxicity from immune checkpoint inhibitors.
Michel L, Rassaf T, Totzeck M. Michel L, et al. Int J Cardiol Heart Vasc. 2019 Sep 7;25:100420. doi: 10.1016/j.ijcha.2019.100420. eCollection 2019 Dec. Int J Cardiol Heart Vasc. 2019. PMID: 31517036 Free PMC article. Review.
Heart failure therapy in patients with advanced cancer receiving specialized palliative care (EMPATICC trial).
Anker MS, Mahabadi AA, Totzeck M, Tewes M, Khan MS, Mincu RI, Hendgen-Cotta UB, Michel L, Mathew B, Drescher O, Schuler M, Keller U, Rieger K, Ahn J, Bullinger L, Modest DP, Denecke C, Kretzler L, Ramer LV, Krug D, Landmesser U, Lehmann LH, Frey N, Bercker S, Laufs U, Böhm M, Mahfoud F, Merkely B, Diek M, Butler J, Veiser A, Heise T, Hellmich M, Placzek M, Friede T, Anker SD, Rassaf T. Anker MS, et al. Among authors: michel l. Eur Heart J. 2026 Mar 5;47(9):1034-1046. doi: 10.1093/eurheartj/ehaf705. Eur Heart J. 2026. PMID: 40884070 Free PMC article. Clinical Trial.
Prevention of cancer-therapy related cardiac dysfunction.
Haj-Yehia E, Michel L, Mincu RI, Rassaf T, Totzeck M. Haj-Yehia E, et al. Among authors: michel l. Curr Heart Fail Rep. 2025 Feb 19;22(1):9. doi: 10.1007/s11897-025-00697-x. Curr Heart Fail Rep. 2025. PMID: 39969700 Free PMC article. Review.
67 results